First patients receive experimental injection in fight against tough blood cancers
Disease control
Recruiting now
This is the first time a new drug called RJK-RT2831 is being tested in people. The main goal is to find a safe dose and check for side effects in about 70 adults with advanced blood cancers like leukemia that have come back or haven't responded to standard treatments. Researchers…
Phase: PHASE1 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC